SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.730
-0.050 (-2.81%)
At close: Jun 27, 2025, 4:00 PM
1.700
-0.030 (-1.73%)
After-hours: Jun 27, 2025, 5:35 PM EDT

SAB Biotherapeutics Statistics

Total Valuation

SABS has a market cap or net worth of $16.07 million. The enterprise value is $10.01 million.

Market Cap 16.07M
Enterprise Value 10.01M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

SABS has 9.29 million shares outstanding. The number of shares has increased by 41.12% in one year.

Current Share Class 9.29M
Shares Outstanding 9.29M
Shares Change (YoY) +41.12%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 20.27%
Owned by Institutions (%) 13.93%
Float 6.44M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 43.69
Forward PS n/a
PB Ratio 0.77
P/TBV Ratio 0.75
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 26.49
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.32.

Current Ratio 1.69
Quick Ratio 1.33
Debt / Equity 0.32
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -135.73

Financial Efficiency

Return on equity (ROE) is -92.35% and return on invested capital (ROIC) is -61.14%.

Return on Equity (ROE) -92.35%
Return on Assets (ROA) -48.28%
Return on Invested Capital (ROIC) -61.14%
Return on Capital Employed (ROCE) -148.57%
Revenue Per Employee $5,997
Profits Per Employee -$544,069
Employee Count 63
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -38.87% in the last 52 weeks. The beta is 0.55, so SABS's price volatility has been lower than the market average.

Beta (5Y) 0.55
52-Week Price Change -38.87%
50-Day Moving Average 1.75
200-Day Moving Average 2.45
Relative Strength Index (RSI) 42.72
Average Volume (20 Days) 17,593

Short Selling Information

The latest short interest is 33,813, so 0.36% of the outstanding shares have been sold short.

Short Interest 33,813
Short Previous Month 36,810
Short % of Shares Out 0.36%
Short % of Float 0.53%
Short Ratio (days to cover) 0.54

Income Statement

In the last 12 months, SABS had revenue of $377,835 and -$34.28 million in losses. Loss per share was -$3.70.

Revenue 377,835
Gross Profit -29.39M
Operating Income -42.29M
Pretax Income -40.32M
Net Income -34.28M
EBITDA -38.71M
EBIT -42.29M
Loss Per Share -$3.70
Full Income Statement

Balance Sheet

The company has $12.85 million in cash and $6.78 million in debt, giving a net cash position of $6.07 million or $0.65 per share.

Cash & Cash Equivalents 12.85M
Total Debt 6.78M
Net Cash 6.07M
Net Cash Per Share $0.65
Equity (Book Value) 21.41M
Book Value Per Share 2.30
Working Capital 6.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.34 million and capital expenditures -$208,188, giving a free cash flow of -$31.55 million.

Operating Cash Flow -31.34M
Capital Expenditures -208,188
Free Cash Flow -31.55M
FCF Per Share -$3.40
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -11,193.25%
Pretax Margin -9,071.77%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -41.12%
Shareholder Yield -41.12%
Earnings Yield -213.23%
FCF Yield -196.26%

Analyst Forecast

The average price target for SABS is $11.80, which is 582.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.80
Price Target Difference 582.08%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 93.62%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on January 5, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jan 5, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

SABS has an Altman Z-Score of -7.2 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.2
Piotroski F-Score 1